Order Article Reprints

Bhat ZR, Kumar M, Sharma N, Yadav UP, Singh T, Joshi G, Pujala B, Raja M, Chatterjee J, Tikoo K, et al. In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice. Molecules. 2022; 27(17):5540. https://doi.org/10.3390/molecules27175540

Bhat, Zahid Rafiq, Manvendra Kumar, Nisha Sharma, Umesh Prasad Yadav, Tashvinder Singh, Gaurav Joshi, Brahmam Pujala, Mohd Raja, Joydeep Chatterjee, Kulbhushan Tikoo, and et al. 2022. "In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice" Molecules 27, no. 17: 5540. https://doi.org/10.3390/molecules27175540

Bhat, Z. R., Kumar, M., Sharma, N., Yadav, U. P., Singh, T., Joshi, G., Pujala, B., Raja, M., Chatterjee, J., Tikoo, K., Singh, S., & Kumar, R. (2022). In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice. Molecules, 27(17), 5540. https://doi.org/10.3390/molecules27175540